Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Dec 19, 2023

BUY
$23.37 - $32.96 $368,521 - $519,746
15,769 Added 128.51%
28,040 $827,000
Q2 2023

Aug 15, 2023

BUY
$23.37 - $32.96 $368,521 - $519,746
15,769 Added 128.51%
28,040 $827,000
Q1 2023

Dec 19, 2023

BUY
$21.91 - $32.67 $131,898 - $196,673
6,020 Added 96.3%
12,271 $282,000
Q1 2023

May 15, 2023

BUY
$21.91 - $32.67 $131,898 - $196,673
6,020 Added 96.3%
12,271 $283,000
Q4 2022

Dec 19, 2023

BUY
$26.28 - $33.92 $164,276 - $212,033
6,251 New
6,251 $173,000
Q4 2022

Feb 15, 2023

BUY
$26.28 - $33.92 $164,276 - $212,033
6,251 New
6,251 $174,000
Q3 2021

Nov 15, 2021

SELL
$48.48 - $78.23 $979,344 - $1.58 Million
-20,201 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$36.89 - $93.56 $745,214 - $1.89 Million
20,201 New
20,201 $1.69 Million

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.